Generation of an induced pluripotent stem cell line from a Chinese Han child with catecholaminergic polymorphic ventricular tachycardia

Generation of an induced pluripotent stem cell line from a Chinese Han child with catecholaminergic polymorphic ventricular tachycardia

TECRL, first reported in a Sudanese family with catecholaminergic polymorphic ventricular tachycardia (CPVT) in 2016. TECRL, is an endoplasmic reticulum (ER) protein preferentially expressed in the heart, playing a role in cardiomyocyte calcium homeostasis. Using Sendaivirus-mediated reprogramming,...

Full description

Bibliographic Details
Main Authors:	Wei Liu, Ting Liu, Tingting Xiao, Lijian Xie, Cuilan Hou, Xunwei Jiang
Format:	Article
Language:	English
Published:	Elsevier 2022-07-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S187350612200160X

Similar Items

Catecholaminergic Polymorphic Ventricular Tachycardia
by: Mohamed Abbas, et al.
Published: (2022-10-01)

Management of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Ekaterina K. Kulbachinskaya, et al.
Published: (2024-05-01)

Diagnosis of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Ekaterina K. Kulbachinskaya, et al.
Published: (2024-09-01)

Generation of catecholaminergic polymorphic ventricular tachycardia patient-specific induced pluripotent stem cell line
by: Sarah Colombani, et al.
Published: (2022-04-01)

Arrhythmogenic Mechanism of Catecholaminergic Polymorphic Ventricular Tachycardia
by: Nian Liu, MD, et al.
Published: (2006-01-01)

Postexertional Supraventricular Tachycardia in Children with Catecholaminergic Polymorphic Ventricular Tachycardia
by: Scott D. N. Else, et al.
Published: (2012-01-01)

CASQ2 variants in Chinese children with catecholaminergic polymorphic ventricular tachycardia
by: Qirui Li, et al.
Published: (2019-11-01)

Clinical and genetic profiles of chinese pediatric patients with catecholaminergic polymorphic ventricular tachycardia
by: Yu Yan, et al.
Published: (2023-12-01)

Taquicardia ventricular polimórfica catecolaminérgica Catecholaminergic polymorphic ventricular tachycardia
by: Marleny Cruz Cardentey
Published: (2012-06-01)

Catecholaminergic polymorphic ventricular tachycardia detected by an implantable loop recorder in a child
by: Yakup Ergül, et al.
Published: (2013-07-01)

Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes
by: Atara Novak, et al.
Published: (2012-07-01)

Electrophysiological Characteristics and Ablation Outcomes in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
by: Lishui Shen, et al.
Published: (2023-12-01)

Generation of two induced pluripotent stem cell lines from catecholaminergic polymorphic ventricular tachycardia patients carrying RYR2 mutations
by: Xiaohui Kong, et al.
Published: (2023-06-01)

Precision medicine in catecholaminergic polymorphic ventricular tachycardia: Recent advances toward personalized care
by: Anthony Siu, et al.
Published: (2023-04-01)

Electrical storms induced by multiple shocks in catecholaminergic polymorphic ventricular tachycardia, spotlight
by: Hisaaki Aoki, et al.
Published: (2024-10-01)

Successful pregnancy in a high-risk catecholaminergic polymorphic ventricular tachycardia patient
by: Inmaculada Mejía Jiménez, et al.
Published: (2022-12-01)

Investigation of Catecholaminergic Polymorphic Ventricular Tachycardia Children in China: Clinical Characteristics, Delay to Diagnosis, and Misdiagnosis
by: He Jiang, et al.
Published: (2018-01-01)

Calcium Release Deficiency Syndrome (CRDS): Rethinking “Atypical” Catecholaminergic Polymorphic Ventricular Tachycardia
by: Alessandra P. Porretta, et al.
Published: (2024-11-01)

Cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia in the light of the medical situation in Japan
by: Masayoshi Mori, et al.
Published: (2024-08-01)

Efficacy of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia Is Mutation-Independent but Reduced by Calcium Overload
by: Hyun Seok Hwang, et al.
Published: (2019-08-01)

Deadly emotional argument: Sudden cardiac death in catecholaminergic polymorphic ventricular tachycardia (CPVT)
by: Michele Violano, et al.
Published: (2022-08-01)

Catecholaminergic polymorphic ventricular tachycardia patients with multiple genetic variants in the PACES CPVT Registry.
by: Thomas M Roston, et al.
Published: (2018-01-01)

Antiarrhythmic Effects of Carvedilol and Flecainide in Cardiomyocytes Derived from Catecholaminergic Polymorphic Ventricular Tachycardia Patients
by: R. P. Pölönen, et al.
Published: (2018-01-01)

Extracorporeal membrane oxygenation for catecholaminergic polymorphic ventricular tachycardia: a case report and literature review
by: Yuna Li, et al.
Published: (2025-01-01)

A Homozygous CASQ2 Mutation in a Japanese Patient with Catecholaminergic Polymorphic Ventricular Tachycardia
by: Taishi Fujisawa, et al.
Published: (2019-01-01)

Generation of human induced pluripotent stem cell lines from three patients affected by Catecholaminergic Polymorphic ventricular tachycardia (CPVT) carrying heterozygous mutations in RYR2 gene
by: Bastien Cimarosti, et al.
Published: (2022-04-01)

Novel mutation in N-terminal fragment of ryanodine receptor 2 causing catecholaminergic polymorphic ventricular tachycardia
by: Sania Jiwani, et al.
Published: (2023-09-01)

Generation of an induced pluripotent stem cell line (SHETi004-A) from a Chinese Han child with left bundle branch block
by: Tingxia Wang, et al.
Published: (2023-12-01)

<i>CASQ2</i>: clinical and genetic insights into catecholaminergic polymorphic ventricular tachycardia across three families
by: Ekaterina K. Kulbachinskaya, et al.
Published: (2023-08-01)

Arrhythmia initiation in catecholaminergic polymorphic ventricular tachycardia type 1 depends on both heart rate and sympathetic stimulation.
by: Tore K Danielsen, et al.
Published: (2018-01-01)

Identifying Features of Cardiac Disease Phenotypes Based on Mechanical Function in a Catecholaminergic Polymorphic Ventricular Tachycardia Model
by: A. Stempien, et al.
Published: (2022-05-01)

Patient-Specific Human Induced Pluripotent Stem Cell Model Assessed with Electrical Pacing Validates S107 as a Potential Therapeutic Agent for Catecholaminergic Polymorphic Ventricular Tachycardia.
by: Kenichi Sasaki, et al.
Published: (2016-01-01)

Clinical Characteristics, Genetic Basis and Healthcare Resource Utilisation and Costs in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia: A Retrospective Cohort Study
by: Cheuk To Chung, et al.
Published: (2022-08-01)

Correction: Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models.
by: Kirsi Penttinen, et al.
Published: (2015-01-01)

Clinical Characteristics, Genetic Findings and Arrhythmic Outcomes of Patients with Catecholaminergic Polymorphic Ventricular Tachycardia from China: A Systematic Review
by: Justin Leung, et al.
Published: (2022-07-01)

Generation of human induced pluripotent stem cell lines from patients with a RYR2 gene variant c.14201A>G (p.Y4734C): Implications for idiopathic ventricular fibrillation and catecholaminergic polymorphic ventricular tachycardia
by: Canan Celiker, et al.
Published: (2024-12-01)

Generation of an isogenic CRISPR/Cas9-corrected control induced pluripotent stem cell line from a patient with autosomal dominant catecholaminergic polymorphic ventricular tachycardia with a heterozygous variant in cardiac calsequestrin-2
by: Ginell N. Ranpura, et al.
Published: (2025-03-01)

Generation of two human induced pluripotent stem cell lines, LUMCi020-A and LUMCi021-A, from two patients with Catecholaminergic Polymorphic Ventricular Tachycardia carrying heterozygous mutations in the RYR2 gene
by: Viviana Meraviglia, et al.
Published: (2020-05-01)

Assessing the impact and safety of implantable cardioverter defibrillators in treating catecholaminergic polymorphic ventricular tachycardia: a systematic review and meta-analysis protocol
by: Xianhui Zhou, et al.
Published: (2024-08-01)

Long-term clinical course of patients with catecholaminergic polymorphic ventricular tachycardia: A more than 10-year follow-up cohort study
by: Ekaterina Kulbachinskaya, et al.
Published: (2024-10-01)